Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Praxis Precision Medicines is a US-based biopharmaceutical company dedicated to developing innovative therapies for neurological disorders. By utilizing precision medicine, the company specifically targets the underlying genetic causes of epilepsy to advance patient care and therapeutic outcomes.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Praxis Precision Medicines is scheduled to report its next quarterly earnings on 11/11/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Praxis Precision Medicines last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at -2.87 USD.
Across its last 3 earnings reports, Praxis Precision Medicines stock moved by ±6.1% on average the following day. The largest reaction was +16% on 08/06/2026; 2 of 3 reactions were positive.
Praxis Precision Medicines has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.